Biogen Inc. (BIIB) vs Centene Corp. (CNC)
A side-by-side comparison of Biogen Inc. and Centene Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
BIIB
Biogen Inc.
$205.61HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
CNC
Centene Corp.
$64.02HealthcareDelayed quote: Jul 28, 2026, 3:59 PM EDT
Total return — BIIB vs CNC
growth of $100 · dividends reinvested · last 25yBIIB +199.9%CNC +4303.7%CNC compounded faster
Log scale — wide-divergence pair
BIIB CNC
BIIB vs CNC: by the numbers
- •CNC is the larger company ($31.61B vs $30.36B market cap).
- •BIIB is profitable (13.92% net margin) while CNC runs a net loss (-2.63%).
- •CNC grew revenue faster over the past five years (10.35% vs -4.80% CAGR).
Metrics side by side
Valuation
| Metric | BIIB | CNC |
|---|---|---|
| P/E ratio | 21.43 | N/A |
| Forward P/E | 15.71 | 18.24 |
| P/S ratio | 3.01 | 0.16 |
| P/B ratio | 1.59 | 1.41 |
| EV / EBITDA | 13.53 | N/A |
| FCF yield | 8.83% | 28.09% |
Profitability
| Metric | BIIB | CNC |
|---|---|---|
| Gross margin | 69.77% | 16.13% |
| Operating margin | 15.65% | -2.82% |
| Net margin | 13.92% | -2.63% |
| ROE | 7.36% | -22.60% |
| ROIC | 6.62% | -13.41% |
Growth (annualized)
| Metric | BIIB | CNC |
|---|---|---|
| Revenue CAGR (5Y) | -4.80% | 10.35% |
| EPS CAGR (5Y) | -18.67% | N/A |
| FCF CAGR (5Y) | -3.59% | -1.39% |
| Total return CAGR (5Y) | -9.48% | -1.97% |
Frequently asked
- Which has grown faster, BIIB or CNC?
- Over the past five years, CNC grew revenue faster — BIIB at a -4.80% CAGR versus CNC at 10.35%.
- Is BIIB or CNC more profitable?
- BIIB runs the higher net margin — BIIB at 13.92% versus CNC at -2.63%.
- How have BIIB and CNC total returns compared?
- Over the past 10 years, BIIB delivered -3.46% and CNC delivered 6.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Biogen P/E ratioCentene P/E ratioBiogen dividend yieldCentene dividend yieldBiogen ROECentene ROEBiogen operating marginCentene operating marginBiogen revenue growthCentene revenue growthBiogen free cash flowCentene free cash flow
Biogen & Centene appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.